Jenny Nater

4PUBLICATIONS
39CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 10, 2025
Single-cell dynamics of breakthrough toxicities after anakinra prophylaxis for axicabtagene ciloleucel in lymphoma.

Matthew J Frigault, Ning Yao, Trisha R Berger

|Jan 04, 2024
Long-term outcomes of patients with large B-cell lymphoma treated with axicabtagene ciloleucel and prophylactic corticosteroids.

Olalekan O Oluwole, Edouard Forcade, Javier Muñoz

|Aug 01, 2023
Axicabtagene Ciloleucel in Combination with the 4-1BB Agonist Utomilumab in Patients with Relapsed/Refractory Large B-Cell Lymphoma: Phase 1 Results from ZUMA-11.

Michael D Jain, David B Miklos, Caron A Jacobson

|Jul 20, 2022
Discovery of a novel genomic alteration that renders leukemic cells resistant to CD19-targeted immunotherapies.

Armin Ghobadi, Jack H Landmann, Alun Carter

Pageof 1

Frequent Collaborators

1 joint publications

Armin Ghobadi

1 joint publications

Mehmet Emrah Selli

1 joint publications

Matthew Baker

1 joint publications

Christopher A Miller